Europe Strips AstraZeneca Of Key Nexium Patent
In a major setback for AstraZeneca PLC, the European Patent Office has rejected a key substance-of-matter patent covering the pharmaceutical company's blockbuster heartburn drug Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article